In particular, a number of soluble endogenous pro-normalizing factors have been described, including PDGF, Angiopoietin 1, TGFβ and Semaphorin 3A45: a detailed investigation of the their involvement, or additional pathways, will help to unveil a novel molecular machinery for tumor vessel normalization. The gene discussed is TGFB1; the disease is neoplasm.